Accessory Protein MRAP2 Reshapes How the Hunger Hormone Ghrelin Signals Through Its Receptor | Research

The takeaway

MRAP2 fundamentally alters ghrelin receptor signaling by silencing its constitutive activity, boosting G protein signaling, and blocking β-arrestin recruitment — each through independent mechanisms.

Triple signaling bias
MRAP2 independently modulates three distinct aspects of ghrelin receptor signaling

What the researchers found

MRAP2 inhibited GHSR1a constitutive activity, enhanced Gαq-dependent signaling, and blocked β-arrestin recruitment/signaling in response to ghrelin, with the Gαq and β-arrestin effects mediated by distinct MRAP2 regions.

Why it matters

GHSR1a is a major drug target for obesity. Understanding how MRAP2 biases its signaling could explain individual differences in ghrelin sensitivity and guide development of more selective anti-obesity drugs.

The numbers in context

MRAP2 inhibited constitutive activity; enhanced Gq signaling; blocked β-arrestin; effects involved distinct MRAP2 regions

How the study worked

In vitro signaling studies measuring GHSR1a constitutive activity, Gαq-dependent signaling, and β-arrestin recruitment in the presence and absence of MRAP2 and its domain variants. Assessed in response to endogenous agonist ghrelin.

Who was studied

Cell-based signaling assays expressing GHSR1a with/without MRAP2

What this study cannot tell us

In vitro study — MRAP2 effects on ghrelin signaling in vivo may differ. Co-expression levels and tissue-specific factors not replicated. Functional consequences for food intake and glucose homeostasis not tested.

How to read the evidence

Preliminary — in vitro signaling characterization providing mechanistic insight but no in vivo validation of physiological relevance.

When this study was published

Published in 2020; MRAP2 is an increasingly recognized regulator of metabolic hormone receptors.

The bigger picture

This study demonstrates that GPCR signaling is not just about the receptor and its ligand — accessory proteins like MRAP2 can fundamentally change which signaling pathways are activated, adding a new layer of complexity to hormone pharmacology.

Questions still open

Does MRAP2 expression vary across brain regions, creating regional differences in ghrelin sensitivity?
Could MRAP2 modulation be a therapeutic strategy for obesity?
Do mutations in MRAP2 that affect ghrelin signaling contribute to human obesity risk?

Common questions

What is constitutive activity and why does it matter for appetite?

The ghrelin receptor is partially active even without ghrelin present, meaning it sends hunger signals even when you're not fasting. MRAP2 silences this baseline activity, which could be important for controlling appetite between meals.

What is biased signaling?

A receptor can activate multiple pathways (like G protein and β-arrestin). Biased signaling means selectively activating some pathways over others. MRAP2 pushes ghrelin signaling toward G protein and away from β-arrestin, which could have different metabolic outcomes.

Read the original research

The GPCR accessory protein MRAP2 regulates both biased signaling and constitutive activity of the ghrelin receptor GHSR1a.

Science signaling, 13(613)

View on PubMed ↗Publisher’s paper ↗

Citation

Rouault, Alix A J; Rosselli-Murai, Luciana K; Hernandez, Ciria C; Gimenez, Luis E; Tall, Gregory G; Sebag, Julien A. (2020). The GPCR accessory protein MRAP2 regulates both biased signaling and constitutive activity of the ghrelin receptor GHSR1a.. Science signaling, 13(613). https://doi.org/10.1126/scisignal.aax4569